[PDF] Top 20 El Presupuesto de La Hacienda Pública Central
Has 10000 "El Presupuesto de La Hacienda Pública Central" found on our website. Below are the top 20 most common "El Presupuesto de La Hacienda Pública Central".
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
... both benefit and be benefited by combination with α PD-1/ α CTLA-4 and ...CTLA-4 checkpoint inhibition, and R adiation (collectively called the “ CPR ” regimen; see ...in immune-related tumor ... See full document
9
Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model
... combined immune checkpoint in- hibition therapy and external beam radiotherapy ...of immune checkpoint targets, including PD-L1, thereby making the tumor more susceptible to ... See full document
141
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
... potential therapeutic targets whose modulation could render the tumor microenvironment more immunologically ...tumor microenvironment of essential nutrients for T cell function, such as ... See full document
15
The spleen in liver cirrhosis: revisiting an old enemy with novel targets
... major immune cell popula- tion within the marginal zone and red pulp ...different immune cell subsets ...systemic immune responses, which have the potential to affect different tissues and ... See full document
11
Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade
... functional modulation of immune ...tumor microenvironment, it is important to find out if the microRNAs that control the expression of immune checkpoints can be secreted by exosomes to effect ... See full document
193
Inflammatory lymphangiogenesis in postpartum breast tissue remodeling
... Finally, it will be important to deter- mine whether lymphangiogenesis actually drives the more invasive breast cancer in these patients or merely correlates with the inflammation that supports its onset. Would ... See full document
58
Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management
... not without risk of perforation and the time benefit until infliximab treatment might be marginal with a waiting time of several days before a colonoscopy can be performed. Currently, it is not known whether ... See full document
7
Immune modulation as a therapeutic strategy in bone regeneration
... The inflammatory phase starts with the formation of a hematoma caused by the influx of blood following tissue injury and vascular disruption. Because of its angiogenetic and osteogenetic potential, the formation of ... See full document
18
The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy
... In the TME, Tregs are considered as the culprit to deteriorate anti-tumor immune responses, which can impede cytokines production and enhance suppressor activity [25, 61]. LAG-3 is essential for maximal Treg ... See full document
12
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
... by immune checkpoint inhibitors appears to be a relatively uncom- mon irAE that is manageable with standard treatment ...subsequent immune checkpoint ...the immune system, such as an ... See full document
12
Implementing TMB measurement in clinical practice: considerations on assay requirements
... Because data have demonstrated that high TMB is a predictive marker for clinical benefit from immuno- therapy, the ability to classify TMB as high or low is essential for predicting response. Defining cut-offs for ... See full document
6
Identification of Nine lncRNAs Signature for Predicting Survival Benefit of Melanoma Patients Treated with Immune Checkpoint Inhibitors
... Abstract: Immune checkpoint inhibitors (ICI) have been widely used in melanoma, but to identify melanoma patients with survival benefit from ICI is still a big ...the immune process and ... See full document
9
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
... PD-1 checkpoint blockade trials [15–17]. Patients included in immune checkpoint block- ade trials were carefully screened and those at elevated risk for autoimmune disease were ...undergoing ... See full document
13
Selective DNA PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy
... When combined with a parenterally administered topoisom- erase II inhibitor, NU5455 did show evidence of increased tox- icity, suggesting that concomitant use of a DNA-PKcs inhibitor with systemic DNA-DSB therapies is ... See full document
90
Conflicting Roles of Connexin43 in Tumor-Induced Inflammation and Cancer Pathology
... Reactive Astrocytes, Immune Cells, and Cx43 Expression in the Glioma Microenvironment 23.. The interaction between tumor cells and their microenvironment is implicated in modulating [r] ... See full document
87
The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer
... Programmed cell death protein 1 (PD-1, CD279) which is homologous to CD28, is an inhibitory immune signaling molecule and regulates adaptive immune responses. PD-1 is not expressed on circulating T cells ... See full document
27
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
... Compared to conventional chemotherapy, ICIs have been noted to display distinct patterns of immune toxic- ities, commonly labeled as immune-related adverse events (irAEs). IrAEs differ from usual toxicities ... See full document
8
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.
... The ERBB family of receptor tyrosine kinases has a central role in the tumorigenesis of many types of solid tumors [46]. The ErbB receptor tyrosine kinase family consists of four cell surface receptors: ErbB1/EGFR/HER1, ... See full document
85
Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation
... the immune system [111, 112], as seen in inoculation experiments using germ-free mouse models [113–115], and gut microbiota have been reported to be centrally involved in carcinogenesis [116, 117], eg in ... See full document
222
Analysis of PD-1 related immune transcriptional profile in different cancer types
... Considering the complexity of TME, the use of PD-1 blockade may not be enough to elicit an effective anti- tumor response. As demonstrated by our results, PD-1 was highly correlated with a diversity of immunomodu- ... See full document
8
Related subjects